Hormone therapy linked to higher risks of GERD
A 2023 study suggests that women who have used menopausal hormone therapy are significantly more likely to develop gastroesophageal reflux disease (GERD).
Content restricted. Requires subscription
A 2023 study suggests that women who have used menopausal hormone therapy are significantly more likely to develop gastroesophageal reflux disease (GERD).